{
  "paper_metadata": {
    "pmid": "30115079",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on TTR gene variants, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.90G>A",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 20,
        "demographics": "9 mutant and 11 wild type, specific demographics not detailed",
        "phenotype": "Transthyretin amyloidosis (ATTR)"
      },
      "penetrance_data": {
        "total_carriers_observed": 9,
        "affected_count": 5,
        "unaffected_count": 4,
        "uncertain_count": null,
        "penetrance_percentage": 55.56,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "Transthyretin amyloidosis",
          "evidence_sentence": "5 (56%) patients carried Val30Met TTR mutation."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "Transthyretin amyloidosis",
          "evidence_sentence": "5 (56%) patients carried Val30Met TTR mutation."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "Transthyretin amyloidosis",
          "evidence_sentence": "5 (56%) patients carried Val30Met TTR mutation."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "Transthyretin amyloidosis",
          "evidence_sentence": "5 (56%) patients carried Val30Met TTR mutation."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms of amyloidosis",
          "evidence_sentence": "4 (44%) mutant ATTR patients carried other mutations."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met mutation is known to be associated with familial amyloid polyneuropathy.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "No specific functional assays were mentioned.",
      "key_quotes": [
        "5 (56%) patients carried Val30Met TTR mutation.",
        "wild-type ATTR amyloidosis patients had no TTR mutation."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted thoroughly from the main text."
  }
}